Status:
COMPLETED
Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial
Lead Sponsor:
National University of Ireland, Galway, Ireland
Collaborating Sponsors:
University College Hospital Galway
Conditions:
Peripheral Arterial Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Remote ischemic Preconditioning (RIPC) is a phenomena first observed in cardio-thoracic patients in which exposing the limbs for periods of short intermittent ischemia produces protective effect on he...
Detailed Description
Peripheral vascular disease (PVD) is a major health problem, affecting approximately 20% of adults over 55 years of age and about 27 million people in North America and Europe . Most PVD is asymptomat...
Eligibility Criteria
Inclusion
- Known moderate PVD
- New claudication patient with Rutherford stage 2 and Fontaine stage 2a symptoms
Exclusion
- Known upper limb PVD
- Severe cardiac condition
- Risk classification for exercise training: class C and above
- Severe respiratory condition
- Previous history of upper limb deep vein thrombosis
- Patients on glibenclamide or nicorandil- May affect RIPC
- Raynaud's Disease
- Contra indications for MRA
- Pregnancy
- Previous major limb amputation affect ability to exercise
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02273232
Start Date
January 1 2015
End Date
May 5 2017
Last Update
September 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Collage Hospital Galway
Galway, Co Galway, Ireland